Patent 11234833 was granted and assigned to NuVasive on February, 2022 by the United States Patent and Trademark Office.
This present subject disclosure provides a novel implant which is readily adjustable to provide a precise angle of lordosis. The implant may be positioned while in low profile, collapsed geometry, and may be expanded when in place to provide a precise angle of lordosis.